{"name": "Shire",
 "permalink": "shire",
 "crunchbase_url": "http://www.crunchbase.com/company/shire",
 "homepage_url": "http://www.shire.com/shireplc/en/home",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "",
 "created_at": "Fri Aug 06 19:02:22 UTC 2010",
 "updated_at": "Sat Mar 30 03:52:41 UTC 2013",
 "overview": "\u003Cp\u003EShire PLC is a specialty biopharmaceutical company. They have a global sales and marketing infrastructure with a broad portfolio of products and direct marketing capability in the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       44],
      "assets/images/resized/0009/6378/96378v1-max-150x150.png"],
     [[150,
       44],
      "assets/images/resized/0009/6378/96378v1-max-250x250.png"],
     [[150,
       44],
      "assets/images/resized/0009/6378/96378v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [{"funding_round":
     {"round_code": "b",
      "source_url": "http://www.neurophage.com/news.html",
      "source_description": "NeuroPhage Pharmaceuticals closes $12.4M Series B round",
      "raised_amount": 12400000.0,
      "raised_currency_code": "USD",
      "funded_year": 2011,
      "funded_month": 3,
      "funded_day": 1,
      "company":
       {"name": "NeuroPhage Pharmaceuticals",
        "permalink": "neurophage-pharmaceuticals",
        "image":
         {"available_sizes":
           [[[150,
              62],
             "assets/images/resized/0012/4531/124531v1-max-150x150.png"],
            [[203,
              84],
             "assets/images/resized/0012/4531/124531v1-max-250x250.png"],
            [[203,
              84],
             "assets/images/resized/0012/4531/124531v1-max-450x450.png"]],
          "attribution": null}}}},
   {"funding_round":
     {"round_code": "b",
      "source_url": "http://www.prexainc.com/pdfs/prexa_051111.pdf",
      "source_description": "Prexa Pharmaceuticals Obtains $7.0 million in Series B Financing",
      "raised_amount": 7000000.0,
      "raised_currency_code": "USD",
      "funded_year": 2011,
      "funded_month": 5,
      "funded_day": 11,
      "company":
       {"name": "Prexa Pharmaceuticals",
        "permalink": "prexa-pharmaceuticals",
        "image":
         {"available_sizes":
           [[[150,
              97],
             "assets/images/resized/0013/2675/132675v1-max-150x150.png"],
            [[250,
              162],
             "assets/images/resized/0013/2675/132675v1-max-250x250.png"],
            [[253,
              164],
             "assets/images/resized/0013/2675/132675v1-max-450x450.png"]],
          "attribution": null}}}},
   {"funding_round":
     {"round_code": "b",
      "source_url": "http://www.finsmes.com/2012/03/promethera-biosciences-raises-e23-6m-series-funding.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
      "source_description": "Promethera Biosciences Raises \u20ac23.6M in Series B Funding",
      "raised_amount": 23600000.0,
      "raised_currency_code": "EUR",
      "funded_year": 2012,
      "funded_month": 3,
      "funded_day": 28,
      "company":
       {"name": "Promethera Biosciences",
        "permalink": "promethera-biosciences",
        "image":
         {"available_sizes":
           [[[150,
              42],
             "assets/images/resized/0007/5857/75857v1-max-150x150.jpg"],
            [[205,
              58],
             "assets/images/resized/0007/5857/75857v1-max-250x250.jpg"],
            [[205,
              58],
             "assets/images/resized/0007/5857/75857v1-max-450x450.jpg"]],
          "attribution": null}}}},
   {"funding_round":
     {"round_code": "d",
      "source_url": "http://www.masshightech.com/stories/2012/10/15/daily1-Promedior-takes-in-3M-investment-from-Shire.html",
      "source_description": "Promedior takes in $3M investment from Shire",
      "raised_amount": 3000000.0,
      "raised_currency_code": "USD",
      "funded_year": 2012,
      "funded_month": 10,
      "funded_day": 15,
      "company":
       {"name": "Promedior",
        "permalink": "promedior",
        "image":
         {"available_sizes":
           [[[150,
              93],
             "assets/images/resized/0008/0744/80744v2-max-150x150.jpg"],
            [[162,
              101],
             "assets/images/resized/0008/0744/80744v2-max-250x250.jpg"],
            [[162,
              101],
             "assets/images/resized/0008/0744/80744v2-max-450x450.jpg"]],
          "attribution": null}}}},
   {"funding_round":
     {"round_code": "a",
      "source_url": "http://www.prnewswire.com/news-releases/armagen-technologies-inc-announces-17-million-series-a-financing-181460481.html",
      "source_description": "ArmaGen Technologies, Inc. Announces $17 Million Series A Financing",
      "raised_amount": 17000000.0,
      "raised_currency_code": "USD",
      "funded_year": 2012,
      "funded_month": 11,
      "funded_day": 29,
      "company":
       {"name": "ArmaGen Technologies",
        "permalink": "armagen-technologies",
        "image":
         {"available_sizes":
           [[[150,
              59],
             "assets/images/resized/0022/3316/223316v1-max-150x150.jpg"],
            [[187,
              74],
             "assets/images/resized/0022/3316/223316v1-max-250x250.jpg"],
            [[187,
              74],
             "assets/images/resized/0022/3316/223316v1-max-450x450.jpg"]],
          "attribution": null}}}},
   {"funding_round":
     {"round_code": "private_equity",
      "source_url": "http://www.finsmes.com/2013/05/neurophage-pharmaceuticals-raises-6-4m-equity-financing.html",
      "source_description": "NeuroPhage Pharmaceuticals Raises $6.4M in Equity Financing",
      "raised_amount": 6400000.0,
      "raised_currency_code": "USD",
      "funded_year": 2013,
      "funded_month": 5,
      "funded_day": 6,
      "company":
       {"name": "NeuroPhage Pharmaceuticals",
        "permalink": "neurophage-pharmaceuticals",
        "image":
         {"available_sizes":
           [[[150,
              62],
             "assets/images/resized/0012/4531/124531v1-max-150x150.png"],
            [[203,
              84],
             "assets/images/resized/0012/4531/124531v1-max-250x250.png"],
            [[203,
              84],
             "assets/images/resized/0012/4531/124531v1-max-450x450.png"]],
          "attribution": null}}}}],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": 565000000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.fiercebiotech.com/story/shire-forges-565m-buyout-deal-movetis/2010-08-03?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Shire forges $565M buyout deal for Movetis",
    "acquired_year": 2010,
    "acquired_month": 8,
    "acquired_day": 3,
    "company":
     {"name": "Movetis",
      "permalink": "movetis",
      "image":
       {"available_sizes":
         [[[150,
            57],
           "assets/images/resized/0006/8511/68511v1-max-150x150.png"],
          [[213,
            81],
           "assets/images/resized/0006/8511/68511v1-max-250x250.png"],
          [[213,
            81],
           "assets/images/resized/0006/8511/68511v1-max-450x450.png"]],
        "attribution": null}}},
   {"price_amount": null,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://finance.yahoo.com/news/Shire-to-buy-Advanced-apf-4251922182.html?x=0\u0026.v=2",
    "source_description": "Shire to buy Advanced BioHealing for $750 million",
    "acquired_year": 2011,
    "acquired_month": 5,
    "acquired_day": 17,
    "company":
     {"name": "Advanced BioHealing",
      "permalink": "advanced-biohealing",
      "image":
       {"available_sizes":
         [[[150,
            62],
           "assets/images/resized/0008/0074/80074v1-max-150x150.jpg"],
          [[238,
            99],
           "assets/images/resized/0008/0074/80074v1-max-250x250.jpg"],
          [[238,
            99],
           "assets/images/resized/0008/0074/80074v1-max-450x450.jpg"]],
        "attribution": null}}},
   {"price_amount": 160000000.0,
    "price_currency_code": "USD",
    "term_code": "cash",
    "source_url": "http://pevc.dowjones.com/article?an=DJFVW00020130325e93ppxssv\u0026from=alert\u0026pid=32\u0026ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020130325e93ppxssv%26from%3dalert%26pid%3d32",
    "source_description": "Shire to Acquire Dry-Eye Drug Developer SARcode Bioscience ",
    "acquired_year": 2013,
    "acquired_month": 3,
    "acquired_day": 25,
    "company":
     {"name": "SARcode Bioscience",
      "permalink": "sarcode-corporation",
      "image":
       {"available_sizes":
         [[[150,
            104],
           "assets/images/resized/0008/4418/84418v5-max-150x150.jpg"],
          [[250,
            174],
           "assets/images/resized/0008/4418/84418v5-max-250x250.jpg"],
          [[450,
            313],
           "assets/images/resized/0008/4418/84418v5-max-450x450.jpg"]],
        "attribution": null}}}],
 "offices":
  [{"description": "Corporate Headquarters",
    "address1": "5 Riverwalk",
    "address2": "Citywest Business Campus",
    "zip_code": "",
    "city": "Dublin",
    "state_code": null,
    "country_code": "IRL",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Shire launches Facebook page for Gaucher disease month",
    "stoned_year": 2010,
    "stoned_month": 9,
    "stoned_day": 3,
    "source_url": "http://www.masshightech.com/stories/2010/08/30/daily66-Shire-launches-Facebook-page-for-Gaucher-disease-month.html",
    "source_text": null,
    "source_description": "Shire launches Facebook page for Gaucher disease month",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Shire",
      "permalink": "shire"}},
   {"description": "Shire HGT appoints Philip Vickers as SVP of R\u0026D",
    "stoned_year": 2010,
    "stoned_month": 10,
    "stoned_day": 11,
    "source_url": "http://www.masshightech.com/stories/2010/10/11/daily67-Shire-HGT-appoints-Vickers-as-senior-VP-of-RD.html",
    "source_text": null,
    "source_description": "Mass High Tech",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Shire",
      "permalink": "shire"}},
   {"description": "Shire plc has named Philip J. Vickers as senior vice president of research and development for the company\u00e2\u20ac\u2122s Human Genetic Therapies division",
    "stoned_year": 2010,
    "stoned_month": 10,
    "stoned_day": 11,
    "source_url": "http://www.masshightech.com/stories/2010/10/11/daily67-Shire-HGT-appoints-Vickers-as-senior-VP-of-RD.html",
    "source_text": null,
    "source_description": "Shire HGT appoints Vickers as senior VP of R\u0026D",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Shire",
      "permalink": "shire"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}